AG˹ٷ

STOCK TITAN

[144] Amprius Technologies, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Amprius Technologies (AMPX) filed a Form 144 notifying a proposed sale of 28,390 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value listed as 193,512. The shares were acquired on 08/20/2025 as a release of restricted stock units from the issuer and were granted as compensation. The filer reports 70,811 shares acquired in that release and shows 125,075,837 shares outstanding. No securities were reported sold by the filer in the past three months. The filing includes the standard signature representation that the filer is not aware of undisclosed material adverse information.

Amprius Technologies (AMPX) ha presentato un Modulo 144 notificando l'intenzione di vendere 28.390 azioni ordinarie tramite Morgan Stanley Smith Barney sul NYSE, per un valore di mercato complessivo indicato di 193.512. Le azioni sono state acquisite il 20/08/2025 come liberazione di unità azionarie vincolate (RSU) dall'emittente e sono state assegnate come compenso. Il dichiarante riferisce di aver ricevuto 70.811 azioni in tale rilascio e indica 125.075.837 azioni in circolazione. Negli ultimi tre mesi non sono state segnalate vendite di titoli da parte del dichiarante. Il deposito contiene la consueta dichiarazione firmata che il dichiarante non è a conoscenza di informazioni materiali sfavorevoli non divulgate.

Amprius Technologies (AMPX) presentó un Formulario 144 notificando una propuesta de venta de 28.390 acciones ordinarias a través de Morgan Stanley Smith Barney en la NYSE, con un valor de mercado agregado indicado de 193.512. Las acciones fueron adquiridas el 20/08/2025 como liberación de unidades restringidas de acciones (RSU) por parte del emisor y se otorgaron como dzԲó. El declarante informa haber recibido 70.811 acciones en ese liberación y muestra 125.075.837 acciones en circulación. No se informaron ventas de valores por parte del declarante en los últimos tres meses. La presentación incluye la firma estándar que declara que el declarante no tiene conocimiento de información adversa material no divulgada.

Amprius Technologies(AMPX)� 양도 예정 주식� 통지하는 Form 144� 제출했으�, NYSE에서 Morgan Stanley Smith Barney� 통해 28,390주의 보통주를 매도� 예정이라� 보고했습니다. � 시장 가치는 193,512� 기재되어 있습니다. 해당 주식은 발행인으로부터의 제한조건부주식단위(RSU) 해제2025-08-20� 취득되었� 보상으로 부여되었습니다. 제출자는 해당 해제� 70,811주를 취득했음� 보고했으�, � 발행주식 수는 125,075,837주로 표시되어 있습니다. 제출자는 최근 3개월� 증권� 매도� 사실� 없다� 보고했습니다. 제출서에� 제출자가 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 서명 진술� 포함되어 있습니다.

Amprius Technologies (AMPX) a déposé un formulaire 144 notifiant un projet de vente de 28 390 actions ordinaires via Morgan Stanley Smith Barney sur le NYSE, pour une valeur de marché totale indiquée de 193 512. Les actions ont été acquises le 20/08/2025 lors de la levée d'unités d'actions restreintes (RSU) accordées par l'émetteur et attribuées comme éܲéپDz. Le déclarant indique avoir acquis 70 811 actions lors de cette levée et fait état de 125 075 837 actions en circulation. Aucune vente de titres par le déclarant n'a été signalée au cours des trois derniers mois. le dépôt contient la déclaration signée habituelle selon laquelle le déclarant n'a pas connaissance d'informations défavorables importantes non divulguées.

Amprius Technologies (AMPX) reichte ein Formular 144 ein und meldete den beabsichtigten Verkauf von 28.390 Stammaktien über Morgan Stanley Smith Barney an der NYSE mit einem angegebenen Gesamtmarktwert von 193.512. Die Aktien wurden am 20.08.2025 als Freigabe von Restricted Stock Units (RSU) durch den Emittenten erworben und als ձüٳܲԲ gewährt. Der Einreicher berichtet, in dieser Freigabe 70.811 Aktien erhalten zu haben, und gibt 125.075.837 ausstehende Aktien an. In den letzten drei Monaten wurden vom Einreicher keine Wertpapiere als verkauft gemeldet. Die Einreichung enthält die übliche unterschriebene Erklärung, dass dem Einreicher keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.

Positive
  • Timely disclosure of proposed sale details including broker, sale date, and share counts
  • Acquisition basis disclosed � shares resulted from a release of restricted stock units dated 08/20/2025
  • No reported sales by the filer in the past three months, simplifying aggregation rules
Negative
  • None.

Insights

TL;DR Routine insider sale notice following an RSU release; no prior sales reported in past three months.

This Form 144 documents a proposed sale of 28,390 common shares tendered to a broker, with acquisition tied to an issuer RSU release dated 08/20/2025 and compensation noted as the payment nature. The filing gives investors transparency about an insider-originated sale and confirms no aggregated sales by this person in the prior three months. The disclosure of shares outstanding (125,075,837) allows investors to contextualize the size of the proposed sale relative to the company’s float.

TL;DR Standard compliance filing; includes required representations about material nonpublic information.

The notice appears to follow Rule 144 procedural requirements: it lists the broker, sale date (08/21/2025), class of securities, and the acquisition basis (release of restricted stock units). The filer affirms they do not possess undisclosed material adverse information and indicates no recent sales to aggregate, which supports compliance with insider trading and disclosure norms. This filing is procedural and does not itself indicate governance changes.

Amprius Technologies (AMPX) ha presentato un Modulo 144 notificando l'intenzione di vendere 28.390 azioni ordinarie tramite Morgan Stanley Smith Barney sul NYSE, per un valore di mercato complessivo indicato di 193.512. Le azioni sono state acquisite il 20/08/2025 come liberazione di unità azionarie vincolate (RSU) dall'emittente e sono state assegnate come compenso. Il dichiarante riferisce di aver ricevuto 70.811 azioni in tale rilascio e indica 125.075.837 azioni in circolazione. Negli ultimi tre mesi non sono state segnalate vendite di titoli da parte del dichiarante. Il deposito contiene la consueta dichiarazione firmata che il dichiarante non è a conoscenza di informazioni materiali sfavorevoli non divulgate.

Amprius Technologies (AMPX) presentó un Formulario 144 notificando una propuesta de venta de 28.390 acciones ordinarias a través de Morgan Stanley Smith Barney en la NYSE, con un valor de mercado agregado indicado de 193.512. Las acciones fueron adquiridas el 20/08/2025 como liberación de unidades restringidas de acciones (RSU) por parte del emisor y se otorgaron como dzԲó. El declarante informa haber recibido 70.811 acciones en ese liberación y muestra 125.075.837 acciones en circulación. No se informaron ventas de valores por parte del declarante en los últimos tres meses. La presentación incluye la firma estándar que declara que el declarante no tiene conocimiento de información adversa material no divulgada.

Amprius Technologies(AMPX)� 양도 예정 주식� 통지하는 Form 144� 제출했으�, NYSE에서 Morgan Stanley Smith Barney� 통해 28,390주의 보통주를 매도� 예정이라� 보고했습니다. � 시장 가치는 193,512� 기재되어 있습니다. 해당 주식은 발행인으로부터의 제한조건부주식단위(RSU) 해제2025-08-20� 취득되었� 보상으로 부여되었습니다. 제출자는 해당 해제� 70,811주를 취득했음� 보고했으�, � 발행주식 수는 125,075,837주로 표시되어 있습니다. 제출자는 최근 3개월� 증권� 매도� 사실� 없다� 보고했습니다. 제출서에� 제출자가 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 서명 진술� 포함되어 있습니다.

Amprius Technologies (AMPX) a déposé un formulaire 144 notifiant un projet de vente de 28 390 actions ordinaires via Morgan Stanley Smith Barney sur le NYSE, pour une valeur de marché totale indiquée de 193 512. Les actions ont été acquises le 20/08/2025 lors de la levée d'unités d'actions restreintes (RSU) accordées par l'émetteur et attribuées comme éܲéپDz. Le déclarant indique avoir acquis 70 811 actions lors de cette levée et fait état de 125 075 837 actions en circulation. Aucune vente de titres par le déclarant n'a été signalée au cours des trois derniers mois. le dépôt contient la déclaration signée habituelle selon laquelle le déclarant n'a pas connaissance d'informations défavorables importantes non divulguées.

Amprius Technologies (AMPX) reichte ein Formular 144 ein und meldete den beabsichtigten Verkauf von 28.390 Stammaktien über Morgan Stanley Smith Barney an der NYSE mit einem angegebenen Gesamtmarktwert von 193.512. Die Aktien wurden am 20.08.2025 als Freigabe von Restricted Stock Units (RSU) durch den Emittenten erworben und als ձüٳܲԲ gewährt. Der Einreicher berichtet, in dieser Freigabe 70.811 Aktien erhalten zu haben, und gibt 125.075.837 ausstehende Aktien an. In den letzten drei Monaten wurden vom Einreicher keine Wertpapiere als verkauft gemeldet. Die Einreichung enthält die übliche unterschriebene Erklärung, dass dem Einreicher keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Amprius (AMPX) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 28,390 common shares through Morgan Stanley Smith Barney on 08/21/2025 with an aggregate market value of 193,512.

How were the shares acquired that are being sold according to the Form 144?

The shares were acquired on 08/20/2025 as a release of restricted stock units and the payment nature is listed as compensation.

Does the filer report any sales of Amprius securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

What is the total number of Amprius shares outstanding reported in the filing?

The filing lists 125,075,837 shares outstanding.

Which broker is handling the proposed sale in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th fl. New York NY 10004.
Amprius Tech

NYSE:AMPX

AMPX Rankings

AMPX Latest News

AMPX Latest SEC Filings

AMPX Stock Data

866.78M
113.25M
8.89%
38.99%
7.38%
Electrical Equipment & Parts
Miscellaneous Electrical Machinery, Equipment & Supplies
United States
FREMONT